Efficacy and Safety of Daclizumab High Yield Process Versus Interferon β 1a in Patients With Relapsing-Remitting Multiple Sclerosis

Authors
Category Primary study
Registry of TrialsClinical Trials Registry - India
Year 2010
This article has no abstract
Epistemonikos ID: 1424dfca235293f54cacf2c7aadb8049d21eeb17
First added on: Apr 16, 2025